Ping Bao Chen, 702911 86Th St, Brooklyn, NY 11223

Mentions for Ping Bao Chen

Career records & work history

Lawyers & Attorneys

Ping Chen, New York NY - Lawyer

Address:

Wilson Elser Moskowitz Edelman & Dick LLP
150 E 42Nd St, New York, NY 10017
212-4903000 (Office)

Licenses:

New York - Currently registered 2004

Education:

Rutgers University

Medicine Doctors

Ping Chen

Specialties:

Physical Medicine & Rehabilitation

Work:

Southeastern Integrated MedicalSoutheast Integrated Medical Rehabilitation Medicine
1315 NW 21 Ave STE 2, Chiefland, FL 32626
352-4931655 (phone) 352-4908641 (fax)
Site

Languages:

English

Description:

Ms. Chen works in Chiefland, FL and specializes in Physical Medicine & Rehabilitation. Ms. Chen is affiliated with UF Health Shands Rehabilitation Hospital.

License Records

Ping Chen

Licenses:

License #: 4704224720 - Expired
Category: Nursing
Issued Date: May 11, 2000
Expiration Date: Mar 31, 2003
Type: RN

Ping Chen resumes & CV records

Resumes

Ping Chen - Livingston, NJ

Work:

FORTRESS Investment Group Mar 2011 to Present
Product controller, Middle Office CITCO Fund Services Ltd Sep 2007 to Mar 2011
Manager, P&L Analytical / Valuation Bank of New York Mellon, NJ - New York, NY Nov 2005 to Aug 2007
Analyst II, Global Asset Management

Education:

Temple University, Fox Business School - Philadelphia, PA May 2005
Master in Finance Philadelphia University - Philadelphia, PA May 2003
Bachelor in Computer & Information Science

Publications & IP owners

Us Patents

Cyclic Protein Tyrosine Kinase Inhibitors

US Patent:

6596746, Jul 22, 2003

Filed:

Apr 13, 2000

Appl. No.:

09/548929

Inventors:

Jagabandhu Das - Mercerville NJ
Ramesh Padmanabha - Hamden CT
Ping Chen - Belle Mead NJ
Derek J. Norris - Trenton NJ
Arthur M. P. Doweyko - Long Valley NJ
Joel C. Barrish - Holland PA
John Wityak - Robbinsville NJ

Assignee:

Bristol-Myers Squibb Company - Princeton NJ

International Classification:

C07D27742

US Classification:

514370, 548194

Abstract:

Novel cyclic compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic and oncologic disorders.

Cyclic Protein Tyrosine Kinase Inhibitors

US Patent:

6979694, Dec 27, 2005

Filed:

Mar 3, 2003

Appl. No.:

10/378372

Inventors:

Jagabandhu Das - Mercerville NJ, US
Ramesh Padmanabha - Hamden CT, US
Ping Chen - Belle Mead NJ, US
Derek J. Norris - Trenton NJ, US
Arthur M. P. Doweyko - Long Valley NJ, US
Joel C. Barrish - Holland PA, US
John Wityak - Robbinsville NJ, US

Assignee:

Bristol-Myers Squibb Company - Princeton NJ

International Classification:

A61K031/426
A61K031/44
C07D277/20
C07D417/12

US Classification:

514342, 514371, 5462707, 548195, 544106, 544133

Abstract:

Novel cyclic compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic and oncologic disorders.

Cyclic Protein Tyrosine Kinase Inhibitors

US Patent:

7091223, Aug 15, 2006

Filed:

Mar 3, 2003

Appl. No.:

10/378461

Inventors:

Jagabandhu Das - Mercerville NJ, US
Ramesh Padmanabha - Hamden CT, US
Ping Chen - Belle Mead NJ, US
Derek J. Norris - Trenton NJ, US
Arthur M. P. Doweyko - Long Valley NJ, US
Joel C. Barrish - Holland PA, US
John Wityak - Robbinsville NJ, US

Assignee:

Bristol-Myers Squibb Company - Princeton NJ

International Classification:

A61K 31/4439
C07D 417/12

US Classification:

514342, 5462707

Abstract:

Novel cyclic compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic and oncologic disorders.

Cyclic Protein Tyrosine Kinase Inhibitors

US Patent:

7125875, Oct 24, 2006

Filed:

Mar 24, 2003

Appl. No.:

10/395503

Inventors:

Jagabandhu Das - Mercerville NJ, US
Ramesh Padmanabha - Hamden CT, US
Ping Chen - Belle Mead NJ, US
Derek J. Norris - Trenton NJ, US
Arthur M. P. Doweyko - Long Valley NJ, US
Joel C. Barrish - Richboro PA, US
John Wityak - Robbinsville NJ, US
Louis J. Lombardo - Belle Mead NJ, US
Francis Y. F. Lee - Yardley PA, US

Assignee:

Bristol-Myers Squibb Company - Princeton NJ

International Classification:

A61K 31/427
A61K 31/496
A61K 31/501

US Classification:

51425219, 514370

Abstract:

Novel cyclic compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic and oncologic disorders.

Cyclic Protein Tyrosine Kinase Inhibitors

US Patent:

7153856, Dec 26, 2006

Filed:

May 26, 2005

Appl. No.:

11/138942

Inventors:

Joel C. Barrish - Richboro PA, US
John Wityak - Carlsbad CA, US
Jagabandhu Das - Mercerville NJ, US
Ping Chen - Belle Mead NJ, US
Derek J. Norris - Pennington NJ, US
Gary Schieven - Lawrenceville NJ, US

Assignee:

Bristol-Myers Squibb Company - Princeton NJ

International Classification:

A61K 31/497
C07D 241/02

US Classification:

51425211, 544357

Abstract:

Novel cyclic compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic and oncologic disorders.

Cyclic Protein Tyrosine Kinase Inhibitors

US Patent:

7189854, Mar 13, 2007

Filed:

May 26, 2005

Appl. No.:

11/138793

Inventors:

Jagabandhu Das - Mercerville NJ, US
Ping Chen - Belle Mead NJ, US
Derek J. Norris - Trenton NJ, US

Assignee:

Bristol-Myers Squibb Company - Princeton NJ

International Classification:

C07D 401/00
C07D 233/44

US Classification:

5462701, 5483321

Abstract:

Novel cyclic compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic and oncologic disorders.

Pyrrolotriazine Kinase Inhibitors

US Patent:

7531539, May 12, 2009

Filed:

Aug 8, 2007

Appl. No.:

11/835456

Inventors:

Brian E. Fink - Yardley PA, US
Ping Chen - Belle Mead NJ, US
Ashok Vinayak Purandare - Pennington NJ, US
Honghe Wan - Pennington NJ, US

Assignee:

Bristol-Myers Squibb Company - Princeton NJ

International Classification:

C07D 487/04
C07D 403/12
C07D 403/14
A61K 31/53
A61P 19/02
A61P 35/00

US Classification:

514243, 544183

Abstract:

The present invention provides compounds of formula IThe formula I compounds inhibit tyrosine kinase activity of such as TrkA, TrkB, TrkC, Jak2, Jak3 and CK2, thereby making them useful as antiproliferative agents for the treatment of cancer and other diseases.

Pyrrolotriazine Kinase Inhibitors

US Patent:

7605160, Oct 20, 2009

Filed:

Aug 8, 2007

Appl. No.:

11/835469

Inventors:

Brian E. Fink - Yardley PA, US
Ping Chen - Belle Mead NJ, US

Assignee:

Bristol-Myers Squibb Company - Princeton NJ

International Classification:

C07D 487/04
C07D 403/12
C07D 403/14
A61K 31/53
A61P 19/02
A61P 35/00

US Classification:

514243, 544183

Abstract:

The present invention provides compounds of formula IThe formula I compounds inhibit tyrosine kinase activity of Trk receptors such as TrkA, TrkB and TrkC thereby making them useful as antiproliferative agents for the treatment of cancer and other diseases.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.